Elliot Ehrich

Person

Lincoln, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions of buprenorphine and μ antagonists
- Patent number 10,806,731
- Issue date Oct 20, 2020
- Alkermes Pharma Ireland Limited
- Daniel R. Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Opioid agonist antagonist combinations
- Patent number 10,758,527
- Issue date Sep 1, 2020
- Alkermes Pharma Ireland Limited
- Daniel Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions of buprenorphine and μ antagonists
- Patent number 10,314,838
- Issue date Jun 11, 2019
- Alkermes Pharma Ireland Limited
- Daniel Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Opioid agonist antagonist combinations
- Patent number 10,195,191
- Issue date Feb 5, 2019
- Alkermes Pharma Ireland Limited
- Daniel Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions of buprenorphine and μ antagonists
- Patent number 10,188,643
- Issue date Jan 29, 2019
- Alkermes Pharma Ireland Limited
- Daniel Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions of buprenorphine and μ antagonists
- Patent number 9,918,978
- Issue date Mar 20, 2018
- Alkermes Pharma Ireland Limited
- Daniel Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions of buprenorphine and μ antagonists
- Patent number 9,913,837
- Issue date Mar 13, 2018
- Alkermes Pharma Ireland Limited
- Daniel Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions of buprenorphine and μ Antagonists
- Patent number 9,498,474
- Issue date Nov 22, 2016
- Alkermes Pharma Ireland Limited
- Daniel Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Opioid agonist antagonist combinations
- Patent number 9,211,293
- Issue date Dec 15, 2015
- Alkermes Pharma Ireland Limited
- Daniel Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions of buprenorphine and μ antagonists
- Patent number 8,822,488
- Issue date Sep 2, 2014
- Alkermes Pharma Ireland Limited
- Daniel Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhalable epinephrine
- Patent number 8,747,813
- Issue date Jun 10, 2014
- Civitas Therapeutics, Inc.
- Richard P. Batycky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhalable epinephrine
- Patent number 8,415,397
- Issue date Apr 9, 2013
- Civitas Therapeutics, Inc.
- Richard P. Batycky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhalable epinephrine
- Patent number 7,947,742
- Issue date May 24, 2011
- Civitas Therapeutics, Inc.
- Richard P. Batycky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Naltrexone long acting formulations and methods of use
- Patent number 7,919,499
- Issue date Apr 5, 2011
- Alkermes, Inc.
- Elliot Ehrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Naltrexone Long Acting Formulations and Methods of Use
- Publication number 20210244818
- Publication date Aug 12, 2021
- Alkermes Pharma Ireland Limited
- Elliot Ehrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS OF BUPRENORPHINE AND µ ANTAGONISTS
- Publication number 20210196703
- Publication date Jul 1, 2021
- Alkermes Pharma Ireland Limited
- Daniel R. Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions of Buprenorphine and µ Antagonists
- Publication number 20190247387
- Publication date Aug 15, 2019
- Alkermes Pharma Ireland Limited
- Daniel R. Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPIOID AGONIST ANTAGONIST COMBINATIONS
- Publication number 20190192505
- Publication date Jun 27, 2019
- Alkermes Pharma Ireland Limited
- Daniel Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions of Buprenorphine and μ Antagonists
- Publication number 20180078543
- Publication date Mar 22, 2018
- Alkermes Pharma Ireland Limited
- Daniel Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS OF BUPRENORPHINE AND μ ANTAGONISTS
- Publication number 20180078542
- Publication date Mar 22, 2018
- Alkermes Pharma Ireland Limited
- Daniel Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Naltrexone Long Acting Formulations and Methods of Use
- Publication number 20180064814
- Publication date Mar 8, 2018
- Elliot Ehrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Opioid Agonist Antagonist Combinations
- Publication number 20170136004
- Publication date May 18, 2017
- Alkermes Pharma Ireland Limited
- Daniel Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHALABLE EPINEPHRINE
- Publication number 20170119699
- Publication date May 4, 2017
- Civitas Therapeutics, Inc.
- Richard P. Batycky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS OF BUPRENORPHINE AND u ANTAGONISTS
- Publication number 20170056392
- Publication date Mar 2, 2017
- Alkermes Pharma Ireland Limited
- Daniel Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS OF BUPRENORPHINE AND u ANTAGONISTS
- Publication number 20160256450
- Publication date Sep 8, 2016
- ALKERMES PHARMA IRELAND LIMITED
- Daniel Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhalable Epinephrine
- Publication number 20150094378
- Publication date Apr 2, 2015
- Civitas Therapeutics, Inc.
- Richard P. Batycky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS OF BUPRENORPHINE AND μ ANTAGONISTS
- Publication number 20150051240
- Publication date Feb 19, 2015
- ALKERMES PHARMA IRELAND LIMITED
- Daniel Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NALTREXONE LONG ACTING FORMULATIONS AND METHODS OF USE
- Publication number 20140155424
- Publication date Jun 5, 2014
- Alkermes, Inc.
- Elliot Ehrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPIOID AGONIST ANTAGONIST COMBINATIONS
- Publication number 20130281388
- Publication date Oct 24, 2013
- Daniel Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhalable Epinephrine
- Publication number 20130253065
- Publication date Sep 26, 2013
- Civitas Therapeutics, Inc.
- Richard P. Batycky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS OF BUPRENORPHINE AND µ ANTAGONISTS
- Publication number 20130190342
- Publication date Jul 25, 2013
- Alkermes Pharma Ireland Limited
- Daniel Deaver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHALABLE EPINEPHRINE
- Publication number 20110237681
- Publication date Sep 29, 2011
- Civitas Therapeutics, Inc.
- Richard P. Batycky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Naltrexone Long Acting Formulations and Methods of Use
- Publication number 20110212985
- Publication date Sep 1, 2011
- Alkermes, Inc.
- Elliot Ehrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Treating alcoholism and alcohol related disorders using...
- Publication number 20090214650
- Publication date Aug 27, 2009
- Alkermes, Inc.
- Elliot Ehrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for Administering Active Agents to CYP3A4 Sensitive Patients
- Publication number 20090022823
- Publication date Jan 22, 2009
- Alkermes, Inc.
- Elliot Ehrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods and compositions for the treatment of brain reward system d...
- Publication number 20070099947
- Publication date May 3, 2007
- Alkermes, Inc.
- Reginald L. Dean
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Trospium containing compositions
- Publication number 20070041912
- Publication date Feb 22, 2007
- Advanced Inhalation Research, Inc.
- Elliot Ehrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for treating alcoholism
- Publication number 20050245461
- Publication date Nov 3, 2005
- Elliot Ehrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for treating alcoholism
- Publication number 20050245541
- Publication date Nov 3, 2005
- Elliot Ehrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Naltrexone long acting formulations and methods of use
- Publication number 20050245558
- Publication date Nov 3, 2005
- Elliot Ehrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for administering active agents to CYP3A4 sensitive patients
- Publication number 20050031713
- Publication date Feb 10, 2005
- Elliot Ehrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for administering active agents to CYP 2D6 sensitive patients
- Publication number 20050032781
- Publication date Feb 10, 2005
- Elliot Ehrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhalable epinephrine
- Publication number 20040076588
- Publication date Apr 22, 2004
- Richard P. Batycky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Elliot Ehrich

Person

Patents Grantslast 30 patents

Compositions of buprenorphine and μ antagonists

Opioid agonist antagonist combinations

Compositions of buprenorphine and μ antagonists

Opioid agonist antagonist combinations

Compositions of buprenorphine and μ antagonists

Compositions of buprenorphine and μ antagonists

Compositions of buprenorphine and μ antagonists

Compositions of buprenorphine and μ Antagonists

Opioid agonist antagonist combinations

Compositions of buprenorphine and μ antagonists

Inhalable epinephrine

Inhalable epinephrine

Inhalable epinephrine

Naltrexone long acting formulations and methods of use

Patents Applicationslast 30 patents

Naltrexone Long Acting Formulations and Methods of Use

COMPOSITIONS OF BUPRENORPHINE AND µ ANTAGONISTS

Compositions of Buprenorphine and µ Antagonists

OPIOID AGONIST ANTAGONIST COMBINATIONS

Compositions of Buprenorphine and μ Antagonists

COMPOSITIONS OF BUPRENORPHINE AND μ ANTAGONISTS

Naltrexone Long Acting Formulations and Methods of Use

Opioid Agonist Antagonist Combinations

INHALABLE EPINEPHRINE

COMPOSITIONS OF BUPRENORPHINE AND u ANTAGONISTS

COMPOSITIONS OF BUPRENORPHINE AND u ANTAGONISTS

Inhalable Epinephrine

COMPOSITIONS OF BUPRENORPHINE AND μ ANTAGONISTS

NALTREXONE LONG ACTING FORMULATIONS AND METHODS OF USE

OPIOID AGONIST ANTAGONIST COMBINATIONS

Inhalable Epinephrine

COMPOSITIONS OF BUPRENORPHINE AND µ ANTAGONISTS

INHALABLE EPINEPHRINE

Naltrexone Long Acting Formulations and Methods of Use

Methods of Treating alcoholism and alcohol related disorders using...

Methods for Administering Active Agents to CYP3A4 Sensitive Patients

Methods and compositions for the treatment of brain reward system d...

Trospium containing compositions

Methods for treating alcoholism

Methods for treating alcoholism

Naltrexone long acting formulations and methods of use

Methods for administering active agents to CYP3A4 sensitive patients

Methods for administering active agents to CYP 2D6 sensitive patients

Inhalable epinephrine